Catecholaminergic polymorphic ventricular tachycardia

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe genetic arrhythmogenic disorder characterized by adrenergically induced ventricular tachycardia (VT) manifesting as syncope and sudden death.



Input patient's signs and symptoms


Narrow down the case reports



Total: 111 (papers)

  


(per page)
Matched Phenotype  Gene  Mutation  MeSH
Rank
(Similarity)
PMID
(PMCID)
1
(23.3%)
29704693
Cardiac Arrest During Spine Surgery in the Prone Position: Case Report and Review of the Literature.
Staartjes VE, Schillevoort SA, Blum PG, van Tintelen JP, Kok WE, Schroder ML.
World Neurosurg. 2018;115:460-467.e1.
Cardiac arrest Spondylolisthesis
Cardiac Arrest Females Homo sapiens Intraoperative Complications Middle Aged Neurosurgical Procedures Prone Position Spondylolisthesis
1
(23.3%)
27167729
Spectrum of clinical manifestations in two young Turkish patients with congenital generalized lipodystrophy type 4.
Akinci G, Topaloglu H, Akinci B, Onay H, Karadeniz C, Ergul Y, Demir T, Ozcan EE, Altay C, Atik T, Garg A.
Eur J Med Genet. 2016;59(6-7):320-4.
Insulin resistance Scoliosis
CAVIN1
c|INS|481_482|GTGA c|SUB|C|259|T p|FS|K|161|S|41 p|SUB|Q|87|*
Cardiac Arrhythmia Females Homo sapiens Homozygote Insulin Resistance Mutation RNA-Binding Proteins Tachycardia, Ventricular
3
(4.0%)
31020160
Asymptomatic ventricular tachycardia: diagnostic pitfalls of Andersen-Tawil syndrome-a case report.
Nguyen D, Ferns SJ.
Eur Heart J Case Rep. 2018;2(3):yty083.
Prolonged QT interval
KCNJ2
p|SUB|D|71|N;RS#:199473369
3
(4.0%)
30849713
Ryanodine receptor 2 (RYR2) mutation: A potentially novel neurocardiac calcium channelopathy manifesting as primary generalised epilepsy.
Yap SM, Smyth S.
Seizure. 2019;67:11-14.
Seizure
RYR2
c|SUB|G|229|A p|SUB|A|77|T
Adult Cardiac Arrhythmia Channelopathies Differential Diagnosis Epilepsy, Generalized Females Homo sapiens Mutation Ryanodine Receptor Calcium Release Channel
3
(4.0%)
30729048
A Homozygous CASQ2 Mutation in a Japanese Patient with Catecholaminergic Polymorphic Ventricular Tachycardia.
Fujisawa T, Aizawa Y, Katsumata Y, Udo A, Ito S, Hatakeyama K, Hirose M, Miyama H, Nakajima K, Nishiyama T, Kimura T, Nitta M, Misumi K, Takatsuki S, Kosaki K, Fukuda K.
Case Rep Genet. 2019;2019:9056596.
Syncope
CASQ2
p|SUB|W|361|X
3
(4.0%)
30546525
High-dose flecainide with low-dose beta-blocker therapy in catecholaminergic polymorphic ventricular tachycardia: A case report and review of the literature.
Steinfurt J, Dechant MJ, Bockelmann D, Zumhagen S, Stiller B, Schulze-Bahr E, Bode C, Odening KE.
J Cardiol Cases. 2015;11(1):10-13.
Sudden cardiac death
3
(4.0%)
30532865
Inefficacious ICD shocks treated with left cardiac sympathetic denervation in a patient with catecholaminergic polymorphic ventricular tachycardia.
Sorgente A, de Asmundis C, Bayrak F, Chierchia GB, Sarkozy A, Noppen M, Brugada P.
J Cardiol Cases. 2011;4(1):e34-e37.
Shock
3
(4.0%)
30296944
(6176516)
Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
Seidlmayer LK, Riediger F, Pagonas N, Nordbeck P, Ritter O, Sasko B.
J Med Case Rep. 2018;12(1):298.
Syncope
Electric Countershock Electrocardiography Exercise Homo sapiens Male Point Mutation Ryanodine Receptor Calcium Release Channel Secondary Prevention Sudden Cardiac Death Tachycardia, Ventricular
3
(4.0%)
30157307
Catecholaminergic polymorphic ventricular tachycardia managed as orthostatic dysregulation and epilepsy in 11- and 15-year-old sisters.
Fujita S, Nishida K, Irabu H, Nakagawa R, Futatani T, Igarashi N, Usuda K, Nagata Y, Ohno S, Horie M, Hatasaki K.
Pediatr Int. 2018;60(11):998-1001.
Syncope
Child Diagnostic Errors Epilepsy Females Homo sapiens Tachycardia, Ventricular
3
(4.0%)
30116135
A rare cause of sudden cardiac arrest: Catecholaminergic polymorphic ventricular tachycardia.
Atik SU, Alp FE, Dedeoglu R, Koka A, Oztunc F, Eroglu AG.
Turk Pediatri Ars. 2018;53(2):124-128.
Syncope
RYR2
c|SUB|G|9110|A p|SUB|G|3037|D
        

Phenotype(s) retrieved from Orphanet

    Total: 4

HPO ID Term Frequency
HP:0004756 Ventricular tachycardia Very frequent (99-80%)
HP:0002321 Vertigo Frequent (79-30%)
HP:0001279 Syncope Occasional (29-5%)
HP:0001645 Sudden cardiac death Occasional (29-5%)


Phenotype(s) retrieved from case reports

    Total: 22

HPO ID Term # of case reports
HP:0001279 Syncope 15
HP:0011675 Arrhythmia 13
HP:0001645 Sudden cardiac death 9
HP:0001695 Cardiac arrest 7
HP:0004308 Ventricular arrhythmia 7
HP:0031273 Shock 7
HP:0004756 Ventricular tachycardia 6
HP:0031677 Polymorphic ventricular tachycardia 5
HP:0001663 Ventricular fibrillation 4
HP:0005110 Atrial fibrillation 3
HP:0012819 Myocarditis 3
HP:0001649 Tachycardia 2
HP:0001657 Prolonged QT interval 2
HP:0004757 Paroxysmal atrial fibrillation 2
HP:0000739 Anxiety 1
HP:0001250 Seizures 1
HP:0001962 Palpitations 1
HP:0002900 Hypokalemia 1
HP:0004758 Effort-induced polymorphic ventricular tachycardia 1
HP:0011703 Sinus tachycardia 1
HP:0011704 Sick sinus syndrome 1
HP:0031628 Aborted sudden cardiac death 1


Causative gene(s) retrieved from Orphanet

    Total: 7

Gene Symbol Gene Name Entrez Gene ID
RYR2 ryanodine receptor 2 6262
CASQ2 calsequestrin 2 845
TRDN triadin 10345
CALM1 calmodulin 1 801
CALM2 calmodulin 2 805
CALM3 calmodulin 3 808
TECRL trans-2,3-enoyl-CoA reductase like 253017